Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV safety study of CSL influenza vaccine in children and adolescents
2014-004131-40Phase 4
- Sponsor
- CSL Limited
- Start
- Jan 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Afluria in influenza, sponsored by CSL Limited. Primary endpoint: Solicited local and systemic adverse events.
02
Drugs
Afluria
03
Conditions
influenza
Beyond the preview
Go deeper on 2014-004131-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004131-40.